Taneli Puumalainen

Summary

Affiliation: National Public Health Institute
Country: Finland

Publications

  1. ncbi Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein--conjugated pneumococcal vaccine in Filipino infants
    Maria Z Rosario Capeding
    Research Institute for Tropical Medicine, Metro Manila, Philippines
    BMC Infect Dis 3:17. 2003
  2. ncbi Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants
    Taneli Puumalainen
    National Public Health Institute, Department of Vaccines, Helsinki, Finland
    Pediatr Infect Dis J 21:309-14. 2002
  3. ncbi Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants
    Taneli Puumalainen
    Department of Vaccinology, National Public Health Institute, Helsinki, Finland
    Pediatr Infect Dis J 22:141-9. 2003
  4. ncbi Functional antibodies elicited by an 11-valent diphtheria-tetanus toxoid-conjugated pneumococcal vaccine
    Taneli Puumalainen
    Department of Vaccinology, National Public Health Institute, Helsinki, Finland
    J Infect Dis 187:1704-8. 2003
  5. ncbi Clinical case review: a method to improve identification of true clinical and radiographic pneumonia in children meeting the World Health Organization definition for pneumonia
    Taneli Puumalainen
    National Public Health Institute, Mannerheimintie 166, FIN 00300 Helsinki, Finland
    BMC Infect Dis 8:95. 2008
  6. ncbi Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria/tetanus-conjugated vaccine: a randomized controlled trial
    Marilla G Lucero
    Research Institute for Tropical Medicine, Muntinlupa, Manila, Philippines
    J Infect Dis 189:2077-84. 2004

Collaborators

Detail Information

Publications6

  1. ncbi Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein--conjugated pneumococcal vaccine in Filipino infants
    Maria Z Rosario Capeding
    Research Institute for Tropical Medicine, Metro Manila, Philippines
    BMC Infect Dis 3:17. 2003
    ..An 11-valent pneumococcal conjugate vaccine could provide significantly larger reduction in pneumococcal disease burden than the currently available 7-valent vaccine formulation in many countries...
  2. ncbi Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants
    Taneli Puumalainen
    National Public Health Institute, Department of Vaccines, Helsinki, Finland
    Pediatr Infect Dis J 21:309-14. 2002
    ..Pneumococcal conjugate vaccines are intended to provide effective protection against pneumococcal infections, but very little information on antibody responses in infants living in countries with high pneumococcal disease burden exists...
  3. ncbi Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants
    Taneli Puumalainen
    Department of Vaccinology, National Public Health Institute, Helsinki, Finland
    Pediatr Infect Dis J 22:141-9. 2003
    ..Understanding the causes and significance of this variation could help to determine the number of doses and timing required for protection against pneumococcal diseases in each country...
  4. ncbi Functional antibodies elicited by an 11-valent diphtheria-tetanus toxoid-conjugated pneumococcal vaccine
    Taneli Puumalainen
    Department of Vaccinology, National Public Health Institute, Helsinki, Finland
    J Infect Dis 187:1704-8. 2003
    ..e., the concentration required for in vitro killing of pneumococci decreased). Both the quantity and quality of antibodies are important in the evaluation of immunogenicity of pneumococcal vaccines...
  5. ncbi Clinical case review: a method to improve identification of true clinical and radiographic pneumonia in children meeting the World Health Organization definition for pneumonia
    Taneli Puumalainen
    National Public Health Institute, Mannerheimintie 166, FIN 00300 Helsinki, Finland
    BMC Infect Dis 8:95. 2008
    ..The definition is also commonly used as an entry criteria or endpoint in different intervention and disease burden studies...
  6. ncbi Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria/tetanus-conjugated vaccine: a randomized controlled trial
    Marilla G Lucero
    Research Institute for Tropical Medicine, Muntinlupa, Manila, Philippines
    J Infect Dis 189:2077-84. 2004
    ..This finding is an important one for countries with financial constraints and high pneumococcal disease burden...